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Abstract
Background: Radiation-induced fibrosis (RIF) is one of the severe long-term side effects of radiation therapy (RT)
with a crucial impact on the development of postoperative wound healing disorders (WHD). The grades of fibrosis vary
between mild to severe depending on individual radiosensitivity. In this study, we have investigated the molecular
pathways that influence RIF and have correlated data from immunohistochemistry (IHC) for von –Willebrand Factor
(vWF) and from Real-Time Polymerase Chain Reaction (RT-PCR) concerning markers such as Transforming Growth
Factor (TGF)-β1, and vWF, with clinical data concerning the occurrence of WHD during follow-up.
Methods: Expression profiles of the genes encoding TGF-β1, vWF, and α-procollagen (PC) were analyzed, by RT-PCR,
in specimens from patients with (n = 20; 25.6 %) and without (n = 58; 74.4 %) a history of previous RT to the head
and neck. Moreover, IHC against vWF was performed. Clinical data on the occurrence of cervical WHDs were analyzed
and correlated.
Results: A statistically significant increase in the expression profiles of α-PC and TGF-β1 was observed in previously
irradiated skin samples (occurrence of RT >91 days preoperatively). vWF showed a statistically significant increase in
non-irradiated tissue. Moreover, analysis of expression profiles in patients with and without WHDs during follow-up
was performed. IHC showed a reduced amount of vessels and structural changes in epidermal tissue post-RT.
Conclusions: The expression of markers of fibrosis and angiogenesis was analyzed in order to gain insight into
molecular pathways that account for structural changes in irradiated skin and that eventually lead to WHDs.
The results are congruent with reports from the literature and are a possible starting point for further
research, as anti-TGF-β1 treatment, for example, could represent new therapeutic opportunities in the management
of previously irradiated patients.
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Background
Whereas operative tumor resection is considered to be
first line therapy in the primary treatment of limited
head and neck malignancies (HNC), radiation therapy
(RT) is one of the essential therapeutic supports. In par-
ticular, in an adjuvant scheme because of tumor size (T),
the presence of lymph node metastasis (N), the local re-
section status (R), or the infiltration of lymph vessels (L),
RT can significantly increase local tumor control and
overall survival [1–4]. The risk of the development of
lymph node metastasis during follow-up is also signifi-
cantly reduced by means of RT [5–7]. Moreover, RT
alone or in combination with chemotherapy is a funda-
mental option in cases of tumor recurrence or primarily
inoperable tumors [8]. Doses of 66–70 Gray (Gy) are
considered to be an effective in RT of the primary tumor
and involved cervical lymph nodes [9].
However, radical tumor resection in combination with
cervical lymphadenectomy, referred to as neck dissection
(ND), is considered to be standard in surgical cancer
treatment for cervical lymph node metastasis. Moreover,
in situations with no clinical evidence for lymph node
metastasis, histological studies have been able to show
an occult occurrence of lymph node metastasis in up to
20–30 % depending on T and location, thereby establish-
ing ND as an essential step in adequate oncological sur-
gery of any invasive HNC [10–12]. In this method, the
incision for cervical lymphadenectomy is placed 2 cm
caudal from the mandibular margin, reaching from the
sternocleidomastoid muscle region to the contralateral
anterior belly of the digastric muscle. However, other
surgical access to the neck, such as the McFee incision
and the hockey stick incision, has been described, when
a resection of the dorso-caudal levels is performed [13].
RT has profound effects, both acute and long-term, on
skin and connective tissue. Wang and colleagues have
been able to show the effect of RT on patients undergo-
ing abdominal surgery in terms of a significantly reduced
wound healing and increasing incidence of wound heal-
ing disorders (WHD) [14]. As preliminary studies by
Rohleder et al. were able to show, blood velocity was
significantly reduced in irradiated cervical skin at 2 mm
depth [15]. However, blood flow parameters were in-
creased in patients with the occurrence of a postope-
rative WHD. Even though these results seem to be
surprising, a review of available literature revealed only
very few studies, that investigated microvascular blood
supply in the head an neck region, whereas tissues of
other regions were subject to experimental analysis [16].
Our study group suggested two possible explanations: (i)
On the one hand many vessels are being dissected
during surgical interventions, leaving tissues that had
an increased blood supply in the first place with reduced
levels of perfusion postoperatively. The susceptibility to
WHD increases respectively. (ii) On the other hand highly
vascularized tissues have an increased risk for small post-
operative bleedings, creating cervical hematomas and con-
sequently enhance the risk for WHD [15].
The influence of RT on arteries and veins has been dem-
onstrated to be dose-dependent [17, 18]. Schultze-Mosgau
et al. have found no structural changes at doses of 40 to
50 Gy, whereas a dose of 60 to 70 Gy results in intimal de-
hiscence, hyalinosis, and a decreased ratio of the media to
total vessel area in arteries [18, 19]. Moreover, RT also has
an effect on connective tissue, as a compromised perfusion
because of pericapillary fibrosis of the host site in micro-
vascular tissue transfer, irregular capillary distribution, and
a reduced amount of capillaries in the connective tissue
have been demonstrated in animal models [19].
RT induces a reactive increased expression of cyto-
kines such as Transforming growth factor (TGF)-β1.
TGF-β1 plays an important role in wound healing by the
stimulation or inhibition of fibroblast proliferation and
microvessel formation [20–22]. Other studies have shown
that the increased expression of TGF-β1 leads to signifi-
cant fibrosis [23]. Increased expression levels of TGF-β1
in irradiated human and porcine skin have been detected
in previous studies [24, 25]. However, other reports seem
to be inconclusive, as in-vitro studies have demonstrated
an inhibition of endothelial cell migration and prolifera-
tion, whereas a stimulation of microvessel formation has
been shown in-vivo [26].
This current study aims to identify the expression levels
of TGF-β1, von –Willebrand Factor (vWF) as an endo-
thelial marker, and α-Procollagen (α-PC) as a marker of
collagen formation and radiation-induced skin fibrosis in
irradiated and non-irradiated cervical skin specimens,
with special emphasis on postoperative WHDs as illus-
trated in Fig. 1. We have investigated expression levels by
using histology, immunohistochemistry, and molecular
biology in terms of real-time reverse transcription poly-
merase chain reaction (RT-PCR) and have correlated with
the occurrence of WHD following ND. This study adds
important information concerning the structural changes
in irradiated cervical skin and the influence of the occur-
rence of WHD after surgery to the neck.
Methods
Patients and clinical data
We adhered to the Declaration of Helsinki on medical
protocol and ethics, and the Institutional Review Board of
the Technische Universität München, Germany approved
the study (no. 3097/11). All participants were informed
extensively and signed an informed consent agreement.
Inclusion criteria were defined as follows: (i) potential
patients had to be inpatients at the Department of Oral and
Maxillofacial Surgery, Technische Universität München,
Germany between January 1, 2012 and December 31, 2012,
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(ii) availability of anamnestic data, (iii) patients had to
undergo surgical procedures involving ND for HNC or
other malignancies, and (iv) tissue specimens from the sur-
gical access to the ND had to be available. A total of 78
patients were included in this study. All patients were
treated by standardized surgical procedures in terms of ND,
tumor resection, and reconstruction by using local or free
flaps. Clinical data were obtained and documented before
surgery (e.g., age, sex, history of RT, history of tobacco/
alcohol abuse, etc.). Data on the occurrence of cervical
WHD with respect to the location, size, onset after surgery,
and the therapeutic interventions (frequent lavage, applica-
tion of local agents, systemic antimicrobial treatment,
operative debridement, etc.) were obtained during the first
30 postoperative days. All data was documented on a
standardized from and any WHD were photographed.
During hospitalization, clinical data on the occurrence of
cervical WHD (location, size, therapeutic intervention) was
obtained at an interval of 30 days postoperatively. The
length of stay in hospital and in the intensive care unit
(ICU) was also documented. Radiation volumes were docu-
mented (range 50.4 to 69.9 Gy).
Tissue samples
Skin samples were collected from incision margins during
ND procedures under standardized conditions. Specimens
with approximate dimensions of 2 × 10 mm were divided
into two pieces under sterile circumstances, one of which
was stored in Allproctect™-Solution (Qiagen, Germany) at
−80 °C, whereas the other half was placed in 4.5 % buffered
formalin for immunohistochemical staining.
Histology/immunohistochemistry
Tissue specimens were embedded in paraffin, cut into
5-μm-thick sections and stained with Hematoxylin and
Eosin (HE-stain) for histological orientation. According to
local standard protocols, immunohistochemical staining for
vWF was performed. The specimens were deparaffinized in
xylene, rehydrated in a graded alcohol series followed by
heat-induced epitope retrieval in Dako target retrieval solu-
tion (DakoCytomation, Denmark) for 20 min. After being
washed with 0.05 M Tris-buffered saline (TBS), specimens
were treated with 3 % H2O2 to block endogenous peroxid-
ase and to avoid false positive results. Incubation of 5 %
bovine serum antibody (PAA Laboratories, UK) was
followed by treatment with primary antibody in a pretested
concentration of 1:200 (DakoCytomation, Denmark; code
No. A 0082). After incubation with the primary antibody,
incubation with the secondary antibody (1:200, ant-rabbit;
Vector Laboratories Inc., USA) for 60 min, and washes with
TBS, streptavidin biotinylated horseradish peroxidase com-
plex (Amersham Biosciences, Germany) was added to the
sections. A diaminobenzidine (DAB) solution (Sigma-
Aldrich, USA) was used for development, which was moni-
tored and standardized for all stainings by using the specific
antibody. Sections were counterstained with hematoxylin.
Negative controls, in which the primary antibody was omit-
ted, were treated alike otherwise. Immunohistochemical
staining was analyzed by using a microscope, and images
were captured with a digital camera (Nikon, Germany).
The thickness of the epidermis was measured, and the
amount of vessels was determined in 10 high power fields
(HPF) within the specimen. All specimens were evaluated
by two independent and specially trained investigators. At
the time of analysis, the investigators were blinded.
RT-PCR
Ribonucleic acid (RNA) isolation was performed by using
the RNeasy® Protect Mini Kit (Qiagen). Beforehand, tissue
samples were comminuted by using a rotor-stator system
(Miccra, ART Labortechnik, Germany) and ultrasonifica-
tion. After measurement of the amount of extracted RNA
by means of a Biophotometer (Eppendorf, Germany), 1 μg
isolated RNA was used for reverse transcription. Reverse
transcription was performed according to the protocol of
the SuperScript™ First Strand Synthesis System (Invitrogen,
Germany). Random primers were used for RT. For RT-
PCR, the cDNA sample, LightCycler® FastStart DNA Mater
SYBR Green I reaction mix (Roche, Germany), forward and
reverse primers, MgCl2, and RNase-free water, were ana-
lyzed by using the LightCycler® 1.0 system (Roche). Primer
specifity was tested by using electrophoretic separation of
the PCR product. Primer specifications are shown in
Table 1. Amplification algorithms were as follows: 10 min
at 95 °C, 40 cycles of 15 s at 94 °C, 10 s at 60 °C, and 10 s
at 72 °C. A melting curve analysis was recorded in
Fig. 1 Cervical wound healing disorder (WHD) in a male patient
(62 years) with a history preoperative radiation therapy with a total
radiation volume of 64 Gy. The WHD is located in the field of the
surgical approach to the neck dissection on the right side. A
superficial suppurative dehiscence with a local inflammation on a
length of approximately 10 cm can be observed. Dichotomized this
is rated as the occurrence of a WHD in postoperative follow-up
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order to test for cDNA fragment consistency. The
amount of RNA was automatically calculated by com-
parison of measured threshold cycles with standard
curves and normalized with glyceraldehyde 3-phosphate
dehydrogenase (GAPDH) as a housekeeping gene. A no
template control was included in each run. All amplifica-
tions were carried out in triplicates.
Statistical analysis
All data were analyzed by using IMB®SPSS® for Mac
(version 22.0; IMB Corp., USA). Means and standard
deviation (SD) were calculated, and tests of significance
were performed. For normally distributed values, t-test
was performed. For values not normally distributed, the
Mann–Whitney test was used. Statistical significance




A total of 78 patients (33 males, 45 females) were in-
cluded in this study. The mean age was 61.1 ± 11.7 years.
A total of 20 patients received RT (25.6 %) before the
surgical intervention because of tumor reoccurrence or
previously non-surgically treated cancers in other centers.
The majority of patients suffered from oral squamous cell
carcinoma (n = 62; 79.5 %). Other less common diagnoses
included malignant diseases of the salivary glands (n = 5;
6.4 %), sarcoma of the head and neck (n = 2; 2.6 %),
CUP—syndrome and basalioma. Most patients (n = 65;
83.3 %) received immediate free flaps for reconstruction,
such as radial forearm flaps (n = 30; 46.2 %), anterolateral
thigh flaps (n = 14; 23.3 %), and osteocutaneous fibula free
flaps (n = 10; 15.4 %).
No difference was evident between the groups with
respect to age (p = 0.500), sex (p = 0.550), or alcohol
(p = 0.422) and nicotine use (p = 0.521). The length of
the in-hospital stay showed statistically significant dif-
ferences between patients with and without a history
of RT (24.1 ± 17.5 days vs. 13.4 ± 5.6 days; p = 0.000).
However, the length of ICU treatment did not reveal
differences between irradiated and non-irradiated patients
(3.7 ± 6.3 vs. 1.78 ± 3.7; p = 0.103).
WHDs of the head and neck were also documented
in clinical follow-up. Of 78 patients, 20 developed cer-
vical WHDs (25.6 %). Generally, irradiated patients
developed WHD earlier than those without a history
of RT (5.9 ± 3.5 days post-op vs. 7.1 ± 3.3 days post-op;
p = 0.429).
A multivariate analysis of clinical factors associated
with the development of cervical WHDs was performed.
The results are detailed in Table 2. Whereas neither age
(p = 0.445) nor tobacco (p = 0.509) and alcohol (p = 0.346)
use seemed to be statistically significant risk factors for
the development of cervical WHG, an increased relative
risk of 3.136 was associated with previous RT to the head
Table 1 Primer sequences and GenBank® accession numbersa of examined genes
Gene Accession no. Sequence 5´to 3 Efficiency in %b
Human procollagen alpha 1 (α-PC) NC_000077.6 Forward CTCGAGGTGGACACCACCCT 104.437
Reverse CAGCTGGATGGCCACATCGG
Tumor growth factor beta 1 (TGF-β1) NC_010448.3 Forward TGGCGATACCTCAGCAACC 95.488
Reverse CTCGTGGATCCACTTCCAG
Human von Willebrand Factor (vWF) NM_000552 Forward GTGACGTGTAATGGGAGACT 95.374
Reverse GTCATTGGCTCCGTTCTCAT
GAPDH NG_007073.2 Forward GAGTCAACGGATTTGGTCGT 96.783
Reverse TTGATTTTGGAGGGATCTCG
aGenBank® is the National Institutes of Health (NIH, USA) genetic sequence database, an annotated collection of all publicly available DNA sequences [38]
bχ=-1+10(-1/slope)






Odds ratio (95 % CI) p Value
Age (yrs)
≥70 21 (26.9) 7 (33.3) 1.536 (0.517–4.565) .445
<70 57 (73.1) 14 (66.7)
Tobacco use
Yes 36 (46.2) 11 (52.4) 1.408 (0.516–3.841) .509
No 42 (53.8) 10 (47.6)
Alcohol use
Yes 49 (62.8) 15 (71.4) 1.691 (0.572–5.003) .346
No 29 (37.2) 6 (28.6)
RT
Yes 20 (25.6) 9 (45.0) 3.136 (1.059–9.292) .035*
No 58 (74.4) 11 (55.0)
Abbreviations: WHD wound healing disorder, RT radiation therapy, CI
confidence interval
Data in parenthesis are percentages, unless noted otherwise. *statistically
significant difference at α=0.05
Logistic regression analysis
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and neck (p = 0.035). Other morbidities such as diabetes
did not account for statistically significant differences.
Histology/immunohistochemistry
In HE-stained sections, the thickness of the epidermis
was measured (Fig. 2a-c). Immunohistochemical staining
for vWF was analyzed according to the amount of ves-
sels per HPF as well as the size of the vessels. For all
investigated approaches, 10 HPFs were analyzed by two
independent investigators, and a mean value was calcu-
lated. Non-irradiated skin showed a regular thickness of
the epidermis, whereas preoperatively irradiated tissue
showed histological signs of epidermal atrophy with sta-
tistically significant differences in the thickness of the
epidermis (98.6 ± 20.3 μm vs. 63.8 ± 12.8 μm; p = 0.000;
Fig. 3d). With regard to vessel density in immunohisto-
chemical staining for vWF, a decrease in irradiated tissue
versus skin that has not been exposed to RT could be
observed (2.0 ± 0.7 vs. 4.4 ± 1.6; p = 0.000; Fig. 3c). Ana-
lysis of vessels size did not reveal statistically significant
differences between the study groups. Photomicro-
graphs of immunostaining for vWF in tissue specimens
with and without a history of previous RT are shown in
Fig. 3a and b.
RT-PCR
The expression of all the investigated genes was analyzed
according to a history of RT and the occurrence of post-
operative WHDs. α-PC showed a statistically significant
higher expression in previously (more than 91 days)
irradiated tissue than in the non-irradiated controls
(9.1E-01 ± 1.1E-01 vs. 2.1 ± 3.4E-01; p = 0.002; Fig. 4a).
However, the expression of α-PC in skin samples that
had developed postoperative WHD was increased, but
Fig. 2 HE-Stain. In previously not irradiated tissue (a; scale bar = 250 μm) sebaceous glands, eccrine sweat glands, hair follicles as well as collagen
and elastic fibres can be found in the epidermis. In irradiated tissue (b; scale bar = 250 μm) an epidermal atrophy with ratification of sweat and
sebaceous glands could be found. No intact hair follicles could be identified. A detail enlargement (c; scale bar = 50 μm) shows hypereosinophilic
superficial epidermal layers as well as inflammatory cells in the dermis. Not shown in this enlargement are hyperpigmentations in the epidermis
and numerous melanophages
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without statistical significance (7.4E-01 ± 1.2E-01 vs.
2.5E-01 ± 2.4E-01; p = 0.067; Fig. 4b). Results of RT-PCR
are displayed in Table 3.
Similar results were observed for the expression analysis
of TGF-β1, with a statistically significant difference between
the irradiated and non-irradiated group (2.3E-03 ± 2.7E-03
vs. 1.1E-03 ± 1.2E-03; p = 0.012; Fig. 4c). An increased
expression within the group without clinical signs of WHDs
during follow-up could be seen, but this showed no signifi-
cant difference (2.1E-03 ± 2.7E-03 vs. 1.2E-03 ± 8.3E-04;
p = 0.245, Fig. 4d). Expression analysis for vWF in pre-
operatively irradiated tissue exhibited a statistically signifi-
cant increase in the RT group (1.5E-01 ± 1.1E-01 vs. 4.3E-
02 ± 2.2E-02; p = 0.005; Fig. 4e). An increased expression in
tissue with a clinical WHD in follow-up could also be
observed in comparison with the non-irradiated control
group (7.8E-02 ± 5.1E-02 vs. 1.6E-01 ± 1.3E-01; p = 0.080;
Fig. 4f).
Discussion
The use of RT in the interdisciplinary treatment of HNC is
accompanied by acute side effects, such as dermatitis,
nausea, edema, mucositis, and swallowing disorders, and
long-term side effects including xerostomia, osteora-
dionecrosis, and even the risk of secondary radiation-
induced malignancies [27]. The individual characteristic of
RT-induced side effects is influenced by the total irradiation
dose, overall treatment time, and tumor localization [28].
Furthermore, several years ago, fibrosis was demonstrated
to be a significant side effect that could impair neck move-
ment. Radiation-induced fibrosis (RIF) and consequently
dysfunction of microcirculation are also structural effects of
RT [29]. This is most easily assessed in skin but is also true
for other organs within the radiation field, as RIF can result
in inadequate ventilation, muscle stiffness, decreased car-
diac output, and delayed wound healing [30, 31]. Previous
studies have shown the essential role of inflammatory
Fig. 3 Results of immunohistochemical analysis. a Histological photograph of vWF staining in non-irradiated cervical skin. Scale bar = 50 μm.
b Histological photograph of vWF staining in irradiated cervical skin. Scale bar = 50 μm. (c + d) Boxplot diagrams visualizing the number of stained
vessels per high power field (HPF) (c); and the measured thickness of the epidermis (d). Given is the median value, (with the 75th percentile and the
25th percentile) calculated over ten HPFs in patients with (n = 27) and without RT (n = 57). The range is shown as a vertical line; extreme values are
excluded. P-values were calculated by means of the Mann–Whitney test. Statistical significance between groups could be shown (both *: p = 0.000)
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cytokines such as TGF-β1 in the pathogenesis of RIF, as fi-
brosis is known to be caused by excess collagen and alter-
ations in the extracellular matrix (ECM) [31]. TGF-β1 is
reported to promote fibrosis and to suppress
vascularization during wound healing and is considered to
play a key role in the molecular pathogenesis of RIF [31].
Wound healing in previously irradiated skin is defect-
ive and can lead to prolonged morbidity because of
wound dehiscence, infections, failure of reconstructive
skin or free flaps, skin necrosis, and persistent fistula
formations. Histopathological characteristics of im-
paired wound healing after RT include RIF and impaired
neovascularization [32]. Clinical parameters such as
oxygen saturation, relative hemoglobin concentration,
and blood velocity do not show significant differences
between patients with or without WHD following RT, as
our own preliminary studies suggest [15]. Nevertheless,
only a few reports in the literature involve the investiga-
tion of the effects of RT in terms of WHD in HNC
patients.
Fig. 4 Boxplot diagrams visualizing the gene expression data of the investigated genes α-Procollagen: a: patients with (n = 18) and without
(n = 31) a history of Radiation Therapy (RT); b: patients with (n = 15) and without (n = 22) occurrence of postoperative Wound Healing Disorders
(WHD). VWF: c: patients with (n = 9) and without (n = 35) a history of RT; d: patients with (n = 10) and without (n = 18) occurrence of WHD.
TGF-β1: e: patients with (n = 18) and without (n = 29) a history of RT; f: patients with (n = 15) and without (n = 22) occurrence of WHD. Measured
by real-time RT-PCR in cervical tissue samples. Given is the median value, (with the 75th percentile and the 25th percentile). The range is shown
as a vertical line; extreme values are excluded. P-values were calculated by mean of the Mann–Whitney test. Statistical significance between
groups could be shown (all *: p < 0.005). WHD =wound healing disorder
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This current study investigates the role of marker pro-
teins such as TGF-β1, vWF, and α-PC in angiogenesis
and fibrosis in cervical tissue samples in patients with
and without preoperative RT. Moreover, the identifica-
tion of key factors in the complex pathophysiology of
debilitating wound healing after RT might represent the
foundation for the evaluation of a potential intersection
for therapeutic interventions in the future. The identifi-
cation of TGF-β1 as an essential cytokine in RIF, α-PC
as a marker of structural changes in the microarchitec-
ture of the skin, and vWF as a significant tool in the
characterization of vascularization mechanisms, i.e., as
specific markers that help to understand the effects of
RT, allows them to be used for immunohistochemical
and molecular analysis. Analysis of clinical data obtained
preoperatively and during follow-up shows a signifi-
cantly increased relative risk of patients developing a
WHD after RT. Length of in-hospital stay also shows
significant differences between irradiated and non-
irradiated patients. WHDs occurred earlier in patients
with a positive history of exposure to ionizing radiation.
In brief, these results underline the importance of an
increased clinical sensitivity in irradiated patients who
have to undergo surgery within the former radiation
field. Special caution should be paid to sufficient wound
closure, including the careful bipolar sealing of small
vessels, the application of multi-layered closure (pla-
tysma, subcutaneous, and superficial skin suture), and
the use of perioperative anti-microbial prophylaxis. This
seems especially important as a reduced rate of postop-
erative WHDs after neck dissection not only cuts down
individual morbidity, but also reduces the time of in-
hospital stay and effort during wound closure and
instantly counters any additional expenses. These clinical
findings and the possibility of identifying patients at risk
preoperatively by easily applicable, accessible, patient
compliant and non-invasive tools, such as tissue spec-
trometry and laser Doppler flowmetry, reveals the im-
portance of sufficient surgical care in patients after RT
of the head and neck [15]. Moreover, the fact that
WHDs occurred earlier in preoperatively irradiated pa-
tients especially emphasizes the first three to six postop-
erative days. This calls for a close clinical evaluation and
the low-threshold use of postoperative antibiotics, par-
ticularly in irradiated patients.
Tissue specimens were collected, and immunohistolo-
gical staining against vWF was performed. The results of
such immunostaining against vWF and the detection of
vessels in the collected skin specimens demonstrate sig-
nificant differences between patients with and without
RT. Moreover, significant differences in skin fibrosis and
epidermal thickness have been histologically established
in the two study groups. These results bolster reports on
skin atrophy, fibrosis, and a reduced neovascularization
in the context of WHD following RT as described in the
literature [32].
Expression analysis of markers in fibrosis and angio-
genesis were carried out subsequently in order to gain
insight into the molecular pathways that account for the
structural changes in irradiated skin and that eventually
lead to WHDs. A statistically significant increase in the
expression of α-PC per GAPDH can be found in study
groups with a history of RT. This supports findings that
radiation-induced dermal fibrosis is associated with an
increased expression of α-PC [33, 34].
Collagen, synthesized by fibroblasts shows an in-
creased expression in the context of inflammatory reac-
tions, as others have demonstrated [35]. These findings
are congruent with the results of the increased expression
analysis of α-PC in patients with a WHD during follow-
up. Whereas fibroblasts in hypertrophic scars do not show
an increased expression of α-PC in experiments in vitro,
an significant increase in scleroderma lesions of Type I
collagen could be found [36].
The results of vWF in RT-PCR expression analysis
have revealed a significant increase in control tissue
samples compared with those after RT and an increase
within the control group in tissue samples that devel-
oped WHD during follow-up. However, as yet, no statis-
tically significant differences have been detected. These
Table 3 Real-time RT-PCR results in groups with/without preoperative RT and with/without postoperative cervical WHDs
Gen Median expression per GAPDH Median expression per GAPDH
RT No RT WHD No WHD
N (%) N (%) p Value N (%) N (%) p Value
α-Procollagen 9.1 E-01 2.1 E-01 0.002* 7.4 E-01 2.5 E-01 0.067
18 (36.7) 31 (63.3) 15 (40.5) 22 (59.5)
TGF-β1 2.3 E-03 1.1 E-03 0.012* 1.2 E-03 2.1 E-03 0.245
18 (38.3) 29 (61.7) 15 (40.5) 22 (59.5)
vWF 4.3 E-02 1.5 E-01 0.005* 7.8 E-02 1.6 E-01 0.080
9 (20.5) 35 (79.5) 10 (35.7) 18 (64.3)
Abbreviations: WHD wound healing disorder, RT radiation therapy, RT-PCR reverse-transcription polymerase chain reaction
Data in parentheses are percentages, unless noted otherwise; *statistically significant difference at α=0.0
Koerdt et al. Radiation Oncology  (2015) 10:202 Page 8 of 10
results reflect the enormous influence of neovasculariza-
tion processes in irradiated skin tissue. A sufficient supply
of epidermal tissue with oxygen in terms of adequate
vascularization is especially important in skin that has
undergone radiation-induced fibrosis, in order to prevent
the incidence of WHD following surgery to the neck
during follow-up. However, not only WHDs but also other
numerous histopathological changes with regard to the
late side effects of RT are affected by an impaired neovas-
cularization [32].
Expression analysis of TGF-β1 has revealed significant
differences between previously irradiated patients and
those without a history of RT. The effect of TGF-β1 in
RIF has been subject to other studies in the literature
[31, 37]. An increase of TGF-β1 in patients with a WHD
during follow-up can be observed, but no significant dif-
ference has been measured in statistical analysis. These
findings are compatible with those from other study
groups. Schultze-Mosgau et al. have demonstrated the
relationship between TGF-β1 and the occurrence of RIF
in a murine animal model and in vitro. The inhibition of
TGF-β1 activity has a substantial effect on collagen syn-
thesis and on matrix-degrading enyzmes such as matrix
metalloproteinase-1 and matrix metalloproteinase-3 [37].
The application of anti-TGF-β1 antibodies results in im-
proved healing of free tissue flaps in previously irradiated
tissue and a reduced expression of pro-fibrotic proteins
such as α-PC [37].
Our current study involves an investigation of the in-
fluence of radiation-induced skin fibrosis on WHDs in a
prospective study setting. Tissue specimens have been
obtained during surgical approaches to the cervical lymph
nodes and analyzed by using immunohistochemistry and
RT-PCR. The occurrence of WHDs has been evaluated
clinically during a postoperative follow-up of 30 days. The
increased expression of marker proteins such as TGF-β1
supports pathogenetic theories on the development of
RIF. However, the molecular mechanism of skin fibrosis in
the close relationship to the occurrence of WHDs during
clinical follow-up are seldomly studied. The current study
adds important information about the expression profiles
of marker proteins of RIF. We have found an increase of
TGF-β1 and α-PC expression in irradiated skin and in
tissue samples with an onset of WHD immediately after
surgery. VWF shows consequently a decrease in irratiated
tissues and occurrence of WHDs.
Conclusions
The results of this current study emphasize the import-
ance of cytokines in skin fibrosis and create perspectives
of the possible clinical applications of specific antibodies.
This should be investigated in further studies.
However, the need for accurate and thoroughly surgery
in patients after RT, especially in head and neck procedures,
is highlighted as the clinical data suggest. This could act as
an attentive reminder to those involved in the complex
surgical care of this specific group of patients in the need
for meticulous oncologic rehabilitation.
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